Literature DB >> 3044582

Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation.

G J Mann1, E A Musgrove, R M Fox, L Thelander.   

Abstract

Ribonucleotide reductase catalyzes the first unique, rate-limiting step in DNA synthesis; both its large (M1) and small (M2) subunits are necessary for activity. While direct studies of M2 expression have previously shown a tight correlation with S phase, the kinetic features of M1-expressing cells have remained ill defined. Therefore we have, using immunofluorescence flow cytometry, analyzed changes in whole cell M1 levels and DNA content during various cell cycle and differentiation events. In asynchronous cultures M1 levels are sustained throughout the cell cycle, including G1 phase when M2 levels and ribonucleotide reductase catalytic activity are known to be very low. In contrast M1 is virtually absent from quiescent lymphocytes but is expressed following mitogen stimulation, shortly before S phase cells appear. M1 declines to low levels in "plateau phase" cultures, the major reduction occurring in cells with 2n (G0/G1) DNA content. HL-60 promyelocytic leukemia cells, induced into either myeloid or monocyte-macrophage differentiation, show a similar marked decrease in M1 levels concomitant with the cessation of cell division. We conclude that the M1 subunit of ribonucleotide reductase is constitutively expressed by cycling cells. It is acquired during stimulated transition from G0 to G1 and is lost during exit to G0 or terminal differentiation. This pattern of expression suggests that determination of cellular M1 content may be useful in distinguishing proliferating (including G1) and quiescent (including G0) cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044582

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Cellular adaptation to down-regulated iron transport into lymphoid leukaemic cells: effects on the expression of the gene for ribonucleotide reductase.

Authors:  C R Chitambar; J P Wereley; T Heiman; W E Antholine; W J O'brien
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

Authors:  M G Davenport; J S Pagano
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Progesterone and DNA damage encourage uterine cell proliferation and decidualization through up-regulating ribonucleotide reductase 2 expression during early pregnancy in mice.

Authors:  Wei Lei; Xu-Hui Feng; Wen-Bo Deng; Hua Ni; Zhi-Rong Zhang; Bo Jia; Xin-Ling Yang; Tong-Song Wang; Ji-Long Liu; Ren-Wei Su; Xiao-Huan Liang; Qian-Rong Qi; Zeng-Ming Yang
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

4.  Nerve growth factor induces cell cycle arrest of astrocytes.

Authors:  Andrea B Cragnolini; Marta Volosin; Yangyang Huang; Wilma J Friedman
Journal:  Dev Neurobiol       Date:  2012-06       Impact factor: 3.964

5.  Human M1 subunit of ribonucleotide reductase: cDNA sequence and expression in stimulated lymphocytes.

Authors:  N J Parker; C G Begley; R M Fox
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

6.  Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.

Authors:  O Olakanmi; B E Britigan; L S Schlesinger
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

7.  Elevated ribonucleotide reductase levels associate with suppressed radiochemotherapy response in human cervical cancers.

Authors:  Charles A Kunos; Tomas Radivoyevitch; Adam Kresak; Dawn Dawson; James Jacobberger; Bin Yang; Fadi W Abdul-Karim
Journal:  Int J Gynecol Cancer       Date:  2012-11       Impact factor: 3.437

8.  Reversal of TNP-470-induced endothelial cell growth arrest by guanine and guanine nucleosides.

Authors:  John Hines; Rong Ju; Ginger E Dutschman; Yung-Chi Cheng; Craig M Crews
Journal:  J Pharmacol Exp Ther       Date:  2010-06-22       Impact factor: 4.030

9.  Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus.

Authors:  N M Carroll; E A Chiocca; K Takahashi; K K Tanabe
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

10.  DNA repair initiation induces expression of ribonucleotide reductase in human chronic lymphocytic leukemia cells.

Authors:  Martha Rodriguez Sandoval; Kumudha Balakrishnan; Rajyalakshmi Luthra; Michael Keating; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2013-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.